1. The predictive capacity of in vitro preclinical models to evaluate drugs for the treatment of retinoblastoma
   Irina L. Sinenko et al, 2023, Experimental Eye Research CrossRef
2. Inhibiting autophagy to boost antitumor immunity with tetramethylpyrazine-loaded and PD-L1-targeting liposomal nanoparticles
   Fei Zhou et al, 2023, European Journal of Pharmaceutical Sciences CrossRef
3. Anti-Gastric Cancer Effect of PurifiedOmphalia lapidescensProtein via Regulating the JAK/STAT3 Signaling Pathway
   Yuqin Xu et al, 2022, Nutrition and Cancer CrossRef
4. Pt(IV) Prodrugs with NSAIDs as Axial Ligands
   Daniil Spector et al, 2021, International Journal of Molecular Sciences CrossRef
5. From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs
   Takashiro Akitsu et al, 2023, Current Pharmaceutical Design CrossRef
6. In vitro triple culture model of retinoblastoma for pre‐clinical investigations
   Devashree Jahagirdar et al, 2023, Biotechnology Journal CrossRef
7. Riding the metal wave: A review of the latest developments in metal-based anticancer agents
   Sara Abdolmaleki et al, 2024, Coordination Chemistry Reviews CrossRef
8. pH-sensitive peptide hydrogel encapsulating the anti-angiogenesis drug conbercept and chemotherapeutic drug dox as a combination therapy for retinoblastoma
   Wen Fan et al, 2024, Materials Advances CrossRef